ArticleHemaSphere2022

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.

Jesse M Tettero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.